Literature DB >> 30938189

The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.

Khalad Maliyar1, Erika L Crowley2,3, Fabian Rodriguez-Bolanos3, Ashley O'Toole3,4,5, Melinda J Gooderham3,4,5.   

Abstract

Acrodermatitis continua of Hallopeau is a rare subtype of pustular psoriasis that presents as a sterile, pustular eruption commonly in the finger tips and toes. This disease inflicts both the skin and nail bed, and causes severe disfigurement of the distal phalanges. Because it is a variant of pustular psoriasis, acrodermatitis continua of Hallopeau is commonly managed with antipsoriatic medications. Common approaches to treatment include topical therapy (corticosteroids, vitamin D analogs, and calcineurin inhibitors), systemic therapy, and in more severe cases, biologic therapy. This review will discuss how acrodermatitis continua of Hallopeau is diagnosed and how it is managed, with a particular emphasis on the use of biologics.

Entities:  

Keywords:  IL-12/23; IL-17; acrodermatitis continua of Hallopeau; anti-TNF; biologic therapy; pustular psoriasis

Year:  2019        PMID: 30938189     DOI: 10.1177/1203475419836435

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  1 in total

1.  Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau.

Authors:  Giulio Rizzetto; Federico Diotallevi; Elisa Molinelli; Giulia Radi; Anna Maria Offidani
Journal:  Skin Appendage Disord       Date:  2021-09-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.